Drug Profile


Alternative Names: AGN-210676

Latest Information Update: 05 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Allergan
  • Class Antiglaucomas; Carboxylic acids; Pyrrolidines; Small molecules
  • Mechanism of Action Prostaglandin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase Unknown Glaucoma; Ocular hypertension

Most Recent Events

  • 14 Oct 2010 Investigation in Glaucoma in USA (unspecified route)
  • 14 Oct 2010 Investigation in Ocular hypertension in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top